Review Article
Volume 10 Issue 9 - 2021
Myths and Realities about Psychoanalysis and Autism. The need for an integrated view from Psychoanalysis and Neurosciences
Ema Ponce de León Leiras*
Clinical Psychologist, PhD, Psychoanalyst, Psychoanalytic Association of Uruguay (Asociación Psicoanalítica del Uruguay-IPA), Montevideo, Uruguay
*Corresponding Author: Ema Ponce de León Leiras, Clinical Psychologist, PhD, Psychoanalyst, Psychoanalytic Association of Uruguay (Asociación Psicoanalítica del Uruguay-IPA), Montevideo, Uruguay.
Received: July 13, 2021; Published: August 28, 2021


The present work discusses widely and with well-founded arguments, the current view of autism and the way that the neurosciences developments, added to prejudices, are used to disqualify psychoanalysis as a treatment in this field.

It analyzes five of the so-called “myths” in this article. They were originated in the historical oscillation of paradigms, that at one time emphasized the environment in the aetiology of autism and today emphasizes the biological, without true integration and without knowledge of the pyschoanalytical approach from an updated perspective.

The author supports the hypothesis that the common denominator as well as the heterogeneity of the DSM V category of ASDs is explained by various combinations of neurobiological vulnerability factors that prevent the adequate reception of responses from the environment and lead to a similar response modality, observed in the behavior and autistic maneuvers. She also maintains that psychoanalysis focuses on the subjectification process of the child with ASD, through a delicate process of construction of the psyche, which gives specificity and efficacy to the psychoanalytic treatment of autism.

Keywords: Autism; Psychoanalysis; Child Psychotherapy; Neurosciences


  1. Fein D., et al. “Optimal outcome in individuals with a history of autism”. Journal of Child Psychology and Psychiatry2 (2013): 195-205.
  2. Muratori F. “Course “Autism Spectrum Disorders” organized by Organizado por Clínica del Niño-Harwood Care”. Held in Montevideo, Uruguay (2018).
  3. Hertz-Picciotto I and Delwiche L. “The risk in autism and the role of age at diagnosis”. Epidemiology 1 (2009): 84-90.
  4. Fisch GS. “Nosology and epidemiology in autism: classification counts”. American Journal of Medical Genetics Part C: Seminars in Medical Genetic 2 (2012): 91-103. 
  5. Durban J. “In the beginning was the world? The changing shape and use of interpretations in the analyses of children on the Autisto-Psychotic Spectrum, Sufrimiento Psíquico”. Autismo e Relacoes Iniciais. Abordagem Psicanalitica. Conferencia llevada a cabo en la V Jornada de Autismo da SBPSP, San Paulo, Brasil (2018).
  6. Gaugler T., et al. “Most genetic risk for autism resides with common variation”. Nature Genetics8 (2014): 881-885.
  7. Solms M and y Turnbull O. “What is neuropsychoanalysis?” Neuropsychoanalysis2 (2011): 133-145.
  8. Damasio A. “Descartes Error: Emotion, Reason and the Human Brain”. Avon Books: New York (1994).
  9. Damasio A. “The Feeling of What Happens; Body and Emotion in the Making of Consciousness”. London: Heinemann (1999).
  10. Alvarez A., et al. “Autism and play-the work of the Tavistock autism workshop”. Child Language Teaching and Therapy1 (1999): 53-64.
  11. Kanner L. “Autistic disturbances of affective contact”. Nervous Child3 (1943): 217-250.
  12. Spitz RA. “Hospitalism: An inquiry into the genesis of psychiatric conditions in early childhood”. The Psychoanalytic Study of the Child1 (1945): 53-74.
  13. Pramparo T., et al. “Prediction of autism by translation and immune/inflammation co-expressed genes in toddlers from pediatric community practices”. JAMA Psychiatry4 (2015): 386-394.
  14. Singletary WM. “An integrative model of autism spectrum disorder. ASD as a neurobiological disorder of experienced environmemental deprivation, early life stress and allostatic overload”. Neuropsychoanalysis2 (2015): 81-119.
  15. Ansermet F. “Irréductible singularité, En P. Sadoun (Edition.), Le spectre autistique trouble-t-il la raison de ceux qui l'approchent? (2016): 11-35.
  16. Ansermet F and y Magistretti P. “A cada cual su cerebro. Plasticidad neuronal e inconsciente”. Buenos Aires, Argentina: Katz (2006).
  17. Ansermet F and Giacobino A. “Autisme. A chacun son génome.Navarin/Le Champ freudien”. Paris, Francia: Navarin (2012).
  18. PDM Task Force. “Psychodynamic Diagnostic Manual. Silver Spring, Estados Unidos: Alliance of Psychoanalytic Organizations (2006).
  19. Greenspan S. “The affect diathesis hypothesis: The Role of Emotions in the Core Deficit in Autism and in the Development of Intelligence and Social Skills”. Journal of Developmental and Learning Disorders1 (2001): 1-44.
  20. Muratori F and Maestro S. “Early signs of autism in the first year of life”. In Signs of Autism in Infants (2018): 46-62.
  21. Conti E., et al. “The first 1000 days of the autistic brain: a systematic review of diffusion imaging studies”. Frontiers in Human Neuroscience 9 (2015):159.
  22. Costanzo V., et al. “Early detection of autism spectrum disorders: from retrospective home video studies to prospective ‘high risk’sibling studies”. Neuroscience and Biobehavioral Reviews 55 (2015): 627-635.
  23. Hoffman J. “Autisme et narration. Autisme: état des lieux et horizons. Sous la direction de Golse B. et Delion P., Edition. Erés, Ramonville Saint-Agne (2006).
  24. Ponce de León Leiras E and Batistelli Viera F. “Reflexôes psicanalíticas sobre un caso como Trastorno do Espectro Autista (TEA)”. Estilos da Clínica2 (2014).
  25. Sandler J., et al. “Psychoanalytic monographs Nº 5. Clinical and Observational Psychoanalytic Research: Roots of a Controversy”. Londres, Inglaterra: Karnac (2000).
  26. Alvarez A and Lee A. “Early forms of relatedness in autism. A longitudinal clinical and quantitative single case study”. Clinical Child Psychology and Psychiatry 9 (2004): 499-518.
  27. Leichsenring F and Rabung S. “Long-term psychodynamic psychotherapy in complex mental disorders: update of a meta-analysis”. The British Journal of Psychiatry: the Journal of Mental Science1 (2011): 15-22.
  28. Levy R., et al. “Psychodynamic Psychotherapy Research-Evidence-Based Practice and Practice-Based Evidence”. Londres, Inglaterra: Human Press (2012).
  29. Luyten P., et al. “Handbook of Psychodynamic Approaches to Psychopthology”. London: Guilford Press (2015).
  30. Nemirovski J., et al. “Outcome of psychodynamic child psychotherapy in routine practice”. European Journal of Psychotherapy and Counselling 3 (2014): 228-244.
  31. AACAP Official Action. “Practice Parameter for Psychodinamic Psychotherapy with Children”. Journal of the American Academy of Child and Adolescent Psychiatry 5 (2012): 591-557.
  32. Steinert C., et al. “Psychodynamic Therapy: As Efficacious as Other Empirically Supported Treatments? A Meta-Analysis Testing Equivalence of Outcomes”. The American Journal of Psychiatry 174 (2017): 943-953.
  33. Fonagy P. “The effectiveness of psychodynamic psychotherapies: an update”. World Psychiatry2 (2015): 137-150.
  34. Thurin JM. “Aspects métodologiques de l’approche psychodynamique (psychanalytique)”. Récupéré de (2018).
  35. Brun A., et al. “Evaluation clinique des psychothérapies psychanalytiques”. Dispositifs individuels, groupaux et institutionnels, Paris: Dunod (2016).
  36. Thurin JM., et al. “Approches psychothérapeutiques de l’autisme. Résultats préliminaires á partir de 50 études intensives de cas”. Neuropsychiatrie de l’Enfance et l’Adoloescence2 (2014): 102-118.
  37. Vecchiato M., et al. “Evaluating the efficacy of psychodynamic treatment on a single case of autism. A qualitative research”. Psychotherapy: Psychopathology, Process and Outcome1 (2016): 49-57.
  38. Lisondo A., et al. “Investigación psicoanalítica y cambios en el autismo: presentando el PRISMA”. Eipea 3 (2017): 25-29.
  39. Leichsenring F and Steinert, C. “Is Cognitive Behavioral Therapy the Gold Standard for Psychotherapy? The Need for Plurality in Treatment and Research”. JAMA: The Journal of the American Medical Association 14 (2017): 1323-1324.
  40. Rosenzweig S. “Some implicit common factors in diverse methods of psychotherapy: “At last the Dodo said, ‘Everybody has won and all must have prizes”. American Journal of Orthopsychiatry 6 (1936): 412-415.
  41. González-Blanch C and y Carral-Fernández L. “Cage up dodo, please! the tale of all psychotherapies being equally effective”. Papeles del Psicólogo/Psychologist Papers2 (2017): 94-106.
  42. Dumas-Mallet S., et al. “Scientific Uncertainty in the Press: How Newspapers Describe Initial Biomedical Findings”. Science Communication1 (2018): 124-141.
  43. Ponce de León, E. “Una propuesta interdisciplinaria: psicoanálisis y psicomotricidad en una técnica conjunta para el tratamiento de niños”. Revista Uruguaya de Psicoanálisis 96 (2002): 109-124.
Citation: Ema Ponce de León Leiras. “Myths and Realities about Psychoanalysis and Autism. The need for an integrated view from Psychoanalysis and Neurosciences”. EC Paediatrics 10.9 (2021): 112-126.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before October 14, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.